Physician profile
Catherine Eileen Oconnor
NPI 1134189434
$1,373.25
in general payments reported to CMS, 2019-2025
12 companies · $19.79 in 2025
The $19.79 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $279 · 2021: $138 · 2022: $152 · 2023: $636 · 2025: $19.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $611 · Food and Beverage: $44.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $611.47 |
| Food and Beverage | $44.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $611.47 | 2023 | Biozorb |
| Genentech USA, INC. | $237.97 | 2019-2021 | |
| Focal Therapeutics, INC. | $155.01 | 2020-2021 | |
| Tactile Systems Technology INC | $151.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $62.58 | 2020 | |
| Amgen INC. | $35.84 | 2020 | |
| Siemens Medical Solutions USA, INC. | $24.26 | 2023 | Acuson Sequoia Diagnostic Ultrasound System |
| Seagen INC. | $21.27 | 2020 | |
| Merck Sharp & Dohme LLC | $19.79 | 2025 | Lynparza, Keytruda |
| Abbvie INC. | $18.77 | 2020 | |
| Eisai INC. | $18.13 | 2020 | |
| Daiichi Sankyo INC. | $16.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.